A detailed history of Black Rock Inc. transactions in Vericel Corp stock. As of the latest transaction made, Black Rock Inc. holds 8,056,828 shares of VCEL stock, worth $387 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,056,828
Previous 7,969,516 1.1%
Holding current value
$387 Million
Previous $415 Million 10.84%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$41.71 - $52.9 $3.64 Million - $4.62 Million
87,312 Added 1.1%
8,056,828 $370 Million
Q1 2024

May 10, 2024

BUY
$32.52 - $52.33 $1.06 Million - $1.7 Million
32,453 Added 0.41%
7,969,516 $415 Million
Q4 2023

Feb 13, 2024

BUY
$30.85 - $37.09 $14.2 Million - $17 Million
459,669 Added 6.15%
7,937,063 $283 Million
Q3 2023

Nov 13, 2023

SELL
$31.69 - $39.25 $4.92 Million - $6.09 Million
-155,204 Reduced 2.03%
7,477,394 $251 Million
Q2 2023

Aug 11, 2023

BUY
$29.0 - $38.37 $5.83 Million - $7.72 Million
201,157 Added 2.71%
7,632,598 $287 Million
Q1 2023

May 12, 2023

SELL
$23.85 - $31.34 $200,459 - $263,412
-8,405 Reduced 0.11%
7,431,441 $218 Million
Q4 2022

Feb 13, 2023

BUY
$17.65 - $27.37 $4.58 Million - $7.11 Million
259,608 Added 3.62%
7,439,846 $196 Million
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $2.09 Million - $3.01 Million
92,494 Added 1.3%
7,180,238 $167 Million
Q2 2022

Aug 12, 2022

SELL
$22.88 - $39.45 $402,916 - $694,714
-17,610 Reduced 0.25%
7,087,744 $178 Million
Q1 2022

May 12, 2022

BUY
$31.69 - $43.29 $1.02 Million - $1.39 Million
32,155 Added 0.45%
7,105,354 $272 Million
Q4 2021

Feb 10, 2022

BUY
$35.2 - $52.6 $6.95 Million - $10.4 Million
197,562 Added 2.87%
7,073,199 $278 Million
Q3 2021

Nov 09, 2021

SELL
$46.35 - $59.75 $5.86 Million - $7.56 Million
-126,488 Reduced 1.81%
6,875,637 $336 Million
Q2 2021

Aug 11, 2021

BUY
$47.2 - $67.81 $331 Million - $475 Million
7,002,125 New
7,002,125 $368 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.27B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.